期刊文献+

铜绿假单胞菌6型O-特异性多糖与破伤风类毒素结合物免疫原性研究 被引量:1

Study on the immunogenicity of a conjugate composed of Pseudomonas aeruginosa(IATS 6)O-specific polysaccharide bound with tetanus toxoid
下载PDF
导出
摘要 目的研制有效防治铜绿假单胞菌感染的疫苗。方法用热酚水法提取铜绿假单胞菌6型(IATS 6)菌株的脂多糖(LPS),去除类脂A并纯化O-特异性多糖(O-SP),用CDAP活化O-SP,己二酸二肼作连接臂,在EDAC作用下,与破伤风类毒素结合制备出O-SP-TT结合物并对该结合物进行小鼠免疫原性试验和免疫保护性试验。结果制备的结合物在小鼠免疫原性试验中,产生了高效价的IgG抗体,与O-SP试验组相比,差异具有统计学意义(P<0.05);免疫保护性试验表明,结合物免疫小鼠能很好的保护5~10 LD50活菌的腹腔攻击。结论该结合物有望成为防治IATS 6型铜绿假单胞菌感染的有效疫苗。 Objective To develop an O-specific polysaccharide (O-SP) based conjugate against Pseudomonas aeruginosa. Methods Lipopolysaccharide(LPS) from Pseudomonas aeruginosa (IATS 6 ) was isolated via hot phenol extraction and then hydrolyzed to obtain O-specific polysaccharide ( O-SP ). O-SP was activated with CDAP,using adipic acid dihydrazide as a linker. Activated O-SP was conjugated to tetanus toxoid via EDAC mediated condensation reaction. Immunogenicity of the conjugate and its immune protection were evaluated in mice. The challenge test was conducted in mice immunized with the conjugate. Results Significantly high IgG anti-IATS 60-SP levels were induced in the mice immunized with the con-jugates comparing with those of immunized with O-SP ( P〈0.05 ). The potency study showed that the mice immunized with the conjugate survived when challenged with bacteria of 5--0 LD50. Conclusion The vaccine is expected to effectively a-gainst IATS 6 Pseudomonas aeruginosa.
出处 《微生物学免疫学进展》 2012年第4期10-14,共5页 Progress In Microbiology and Immunology
关键词 铜绿假单胞菌 O-特异性多糖 结合疫苗 免疫原性 免疫保护性 Pseudomonas aeruginosa O-specific polysaccharide ( O-SP ) Conjugate Immunogenicity Vaccine potency
  • 相关文献

参考文献9

  • 1Akhabue E, Synnestvedt M, Weiner M G, et al. Cefepime-resist- ant Pseudomonas aerugi-nosa [ J]. EID Journal, 2011,17 ( 6 ) :1037-1043. 被引量:1
  • 2Mesaros N, Nordmann P, Plesiat P, et al. Pseudomonas aerugi- nosa : resistance and therapeutic options at the turn of the new mil- lenninm[J]. Clin Microbiol Infect, 2007, 13:560-578. 被引量:1
  • 3Doring G, Pier G B. Vaccines and immunotherapy against Pseudo- rnonas aeruginosa [ J]. Vaccine, 2008, 26 : 1011-1024. 被引量:1
  • 4de Bentzmann S, P16siat P. The Pseudomonas aeruginosa oppor- tunistic pathogen and human infections [ J ]. Environ Microbiol, 2011,13(7) :1655-1665. 被引量:1
  • 5Gales A C, Jones R N, Tumidge J, et al. Characterization of Pseudomonas aeruginosa isolates [ J ]. Clin Infect Dis, 2001,32 ($2) : 146-155. 被引量:1
  • 6Kossaczka Z, Shiloach J, Ohnson V, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice [ J ]. Infect Immun, 2000, 68 (9) : 50375 -043. 被引量:1
  • 7Lees A, Nelson B L, Mond J J. Activation of soluble polysaccha- rides with 1-cyano-4-dimethyl amino pyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immuno- logical reagents[J]. Vaccine, 1996, 14(3) :190-198. 被引量:1
  • 8Hota S, Hirji Z, Stockton K, et al. Outbreak ofmuhidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design[ J]. Infect Control Hosp Epidemiol, 2009, 30 ( 1 ) :25-29. 被引量:1
  • 9Knirel Y A, Vinogradov E V, Kocharova N A, et al. The struc- ture of O-specific polysacchari-des and serological classification of Pseudomonas aeruginosa [ J ]. Acta Microbiologica Hungarica, 1988, 35(1) :3-24. 被引量:1

同被引文献9

  • 1Kossaczka Z, Shiloaeh J, Ohnson V, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice[J]. Infect lmmun, 2000, 68 ( 9 ) : 5037 -5043. 被引量:1
  • 2Tam VH, Chang KT, Abdelraouf K, et al. Prevalence, resistance mechanisms, and susceptibility of muhidrug-resistant bloodstream isolates of Pseudonwnas aeruginosa[J]. Antimicrob Agents Che- mother, 2010, 54(3) :1160-1164. 被引量:1
  • 3Kamei A, Wu WH, Traficante DC, et al. Collaboration between maerophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutrope- nia[J]. J Infect Dis, 2013, 207(1) :39-49. 被引量:1
  • 4Akhabue E, Synnestvedt M, Weiner MG, et al. Cefepime-resist- ant Pseudomonas aeruginosa [ J ]. EID J, 2011,17 ( 6 ) : 1037- 1043. 被引量:1
  • 5Doring G,Pier GB. Vaccines and immunotherapy against Pseudo- monas aeruginosa [ J ]. Vaccine, 2008, 26 ( 8 ) : 1011 - 1024. 被引量:1
  • 6de Bentzmann S, Pl~siat P. The Pseudomonas aer~ginosa oppor- tunistic pathogen and human infections [J]. Environ Microbiol, 2011,13 (7) :1655-1665. 被引量:1
  • 7Hota S, Hirji Z, Stockton K, et al. Outbreak of multidrug-resist- ant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design [ J]. Infect Control Hosp Epidemiol, 2009, 30( 1 ) :25-29. 被引量:1
  • 8Knirel YA, Vinogradov EV, Kocharova NA, et al. The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa [ J ]. Acta Micmbiologica Hungarica, 1988, 35(1) :3-24. 被引量:1
  • 9谢茂超,陈明拓,姜晓,杨硕,吴鸿舟,王学林,赵高梅,葛永红.铜绿假单胞菌3型O-特异性多糖-破伤风类毒素结合疫苗的制备及其免疫特性分析[J].中国生物制品学杂志,2012,25(12):1565-1568. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部